Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.9 USD | +0.53% | +1.06% | -19.15% |
09/05 | Transcript : Xeris Biopharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q1 Revenue $40.6M, vs. Street Est of $41.8M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.15% | 28Cr | |
+31.03% | 59TCr | |
-3.42% | 36TCr | |
+18.02% | 33TCr | |
+4.27% | 29TCr | |
+14.85% | 24TCr | |
+9.87% | 21TCr | |
-7.77% | 20TCr | |
+8.12% | 17TCr | |
-1.42% | 16TCr |
- Stock Market
- Equities
- XERS Stock
- News Xeris Biopharma Holdings, Inc.
- Xeris Biopharma Reports First Participant Dosed in Mid-Stage Hypothyroidism Trial